Patents by Inventor Warren Michael Casey

Warren Michael Casey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030232341
    Abstract: Provided is a method of identifying a selected nucleotide in a first nucleic acid utilizing a mobile solid support, as well as a novel read-out method for improving the use of mobile solid support-based read-out technologies for detection of nucleic acid polymorphisms in a target nucleic acid.
    Type: Application
    Filed: June 12, 2002
    Publication date: December 18, 2003
    Inventors: Warren Michael Casey, Jingwen Chen, Heidi Muth Colton, James David Taylor, Michael Philip Weiner
  • Publication number: 20020187470
    Abstract: Provided is a method of identifying a selected nucleotide in a first nucleic acid utilizing a mobile solid support, as well as a novel read-out method for improving the use of mobile solid support-based read-out technologies for detection of nucleic acid polymorphisms in a target nucleic acid.
    Type: Application
    Filed: December 21, 2000
    Publication date: December 12, 2002
    Inventors: Warren Michael Casey, Jingwen Chen, Heidi M. Colton, David Taylor, Michael Phillip Weiner
  • Patent number: 6004968
    Abstract: The present invention relates to pharmaceutical formulations containing (2R, cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2 -one (-)-2',3'-dideoxy,3'-thiacytidine, lamivudine, that are substantially free of ethanol and ethylenediamine-tetraacitic acid, and their use in medical therapy.
    Type: Grant
    Filed: March 20, 1998
    Date of Patent: December 21, 1999
    Assignee: Glaxo Wellcome Inc.
    Inventors: Warren Michael Casey, Ngoc-Anh Thi Nguyen